Literature DB >> 15044001

Polyvalency of Tn (GalNAcalpha1-->Ser/Thr) glycotope as a critical factor for Vicia villosa B4 and glycoprotein interactions.

Albert M Wu1.   

Abstract

Vicia villosa B(4) (VVL-B(4)) is an important lectin for detecting exposed Tn (GalNAcalpha1-Ser/Thr) determinants on cancer cells. In order to elucidate the binding factors involved in VVL-B(4) and glycotope interaction, the binding properties of this lectin were analyzed by enzyme-linked lectinosorbent and inhibition assays. From the results, it is concluded that the most critical factor affecting VVL-B(4) binding is polyvalency at the alpha anomer of Gal with -NH CH(3)CO at carbon-2 (Tn epitope), which enhances the reactivity by 3.3x10(5) times over monovalent Gal. The reactivities of glycotopes can be ranked as follows: high density Tn cluster >>Tn glycopeptides (MW<3.0x10(3) >> monomeric Tn to tri- Tn glycopeptides >>> other GalNAcalpha/beta-related structural units>Gal and Galalpha- or beta-linked ligands, demonstrating the essential role of the polyvalency of Tn glycotopes in the enhancement of the binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044001     DOI: 10.1016/S0014-5793(04)00180-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Carbohydrate specificity of an insecticidal lectin isolated from the leaves of Glechoma hederacea (ground ivy) towards mammalian glycoconjugates.

Authors:  Tanuja Singh; June H Wu; Willy J Peumans; Pierre Rougé; Els J M Van Damme; Richard A Alvarez; Ola Blixt; Albert M Wu
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  Differential binding to glycotopes among the layers of three mammalian retinal neurons by man-containing N-linked glycan, T(alpha) (Galbeta1-3GalNAcalpha1-), Tn (GalNAcalpha1-Ser/Thr) and I (beta)/II (beta) (Galbeta1-3/4GlcNAcbeta-) reactive lectins.

Authors:  Wei-Chi Wu; Chi-Chun Lai; Jia-Hau Liu; Tanuja Singh; Lien-Ming Li; Willy J Peumans; Els J M Van Damme; Albert M Wu
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

3.  An array-based method to identify multivalent inhibitors.

Authors:  Yalong Zhang; Qian Li; Luis G Rodriguez; Jeffrey C Gildersleeve
Journal:  J Am Chem Soc       Date:  2010-07-21       Impact factor: 15.419

4.  Cytochemical study of role of alpha-d-mannose- and beta-d-galactose-containing glycoproteins in apoptosis.

Authors:  R O Bilyy; V O Antonyuk; R S Stoika
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

Review 5.  Lectins and ELLSA as powerful tools for glycoconjugate recognition analyses.

Authors:  Albert M Wu; Jia Hau Liu
Journal:  Glycoconj J       Date:  2019-04-16       Impact factor: 2.916

6.  GalNAc-Tyrosine Is a Ligand of Plant Lectins, Antibodies, and Human and Murine Macrophage Galactose-Type Lectins.

Authors:  Ruslan Gibadullin; David Wayne Farnsworth; Joseph J Barchi; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2017-07-14       Impact factor: 5.100

7.  Differential affinities of Erythrina cristagalli lectin (ECL) toward monosaccharides and polyvalent mammalian structural units.

Authors:  Albert M Wu; June H Wu; Ming-Sung Tsai; Zhangung Yang; Nathan Sharon; Anthony Herp
Journal:  Glycoconj J       Date:  2007-09-06       Impact factor: 2.916

Review 8.  Lectins as tools in glycoconjugate research.

Authors:  Albert M Wu; Elwira Lisowska; Maria Duk; Zhangung Yang
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

9.  Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.

Authors:  Oyindasola Oyelaran; Qian Li; David Farnsworth; Jeffrey C Gildersleeve
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

10.  Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment.

Authors:  Iwona Radziejewska; Małgorzata Borzym-Kluczyk; Zbigniew Namiot; Ewa Stefańska
Journal:  Clin Exp Med       Date:  2010-10-17       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.